Up to 60 invited participants joint the meeting and discussed the outcomes of the ICPerMed Working Groups and the ending ERA Net ERA PerMed as well as internationalisation of ICPerMed and aspects of prevention in personalised medicine. At the end of the meeting an outlook about the new European Partnership for Personalised Medicine (EP PerMed) was given and the importance of the sustainability of ICPerMed achievements was emphasized.
Even if most of the CSAs of the ICPerMed Family have ended or will be ending soon, ICPerMed will offer a platform to collect the CSAs’ results and make them available. In collaboration with EP PerMed, ICPerMed will continue to form a suitable framework to foster the development and implementation of PM.
